The global male infertility market size was US$ 3,834 million in 2021. The global male infertility market size is forecast to reach US$ 5,885 million by 2030, growing at a compound annual growth rate (CAGR) of 5.0% during the forecast period from 2022 to 2030.

The inability of a male to cause pregnancy in a fertile woman is known as male fertility. Infertility in men is caused by problems with sperm production, concentration, or transit. Male infertility is caused by a variety of illnesses, including medical issues, psychological issues, and hormone imbalances. In some situations, male infertility is caused by testicular injury, which results in the testicle's inability to generate sperm. This feature of male infertility is related to menopause (but not natural like menopause) in that the injured testicle is usually unable to regain its sperm-making potential.

Factors Influencing Market Growth
Among the factors driving the global market include transforming lifestyles, growing ages, extra consumption of alcohol and drugs, environmental elements, and genetic irregularities.

The increased cost of treatment may slow down the overall industry growth.

Progress in infertility treatments and developing healthcare infrastructure is forecast to offer lucrative opportunities for the global market.

The increased popularity of assisted reproductive technology (ART) boosts the global market growth.

Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide imposed a lockdown in order to curb the spread of the deadly virus. This had halted all the non-essential emergency medical procedures. As a result, various fertility clinics and hospitals had to close their services. Many other hospitals and clinics were focusing on the treatment of COVID-19 patients. This declined the demand for fertility services.

Regional Analysis
Europe had substantial growth in 2021. As a result of the availability of developed fertility facilities, raising awareness, and increasing acceptance of more costly therapy.

North America accounted for a significant market share. As a result of the rising male infertility driven by lifestyle changes like obesity and diet.

The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing elderly population and a surge in lifestyle-related disorders.

Leading Competitors
The leading prominent companies profiled in the global male infertility market are:
ASKA Pharmaceutical Co. Limited
ZydusCadila Healthcare Limited,
Access Pharmaceuticals, Incorporated
Intas Pharmaceuticals Limited
Pantarhei Bioscience B
Cordex Pharma, Incorporated
Merck Serono
Halotech DNA SL,
SCSA diagnostics,
Andrology Solutions.
Other Prominent Players

Scope of the Report
The global male infertility market segmentation focuses on Test, Treatment, End-User, and Region.
Segmentation based on Test
Oxidative Stress Analysis
DNA Fragmentation Technique
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Others
Segmentation based on Treatment
Medication
Assisted Reproductive Technology and Varicocele Surgery
Segmentation based on End-User
Hospitals and Clinics
Fertility Centers
Research Institutes
Others
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Male Infertility Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Male Infertility Market is projected to reach US$ 5,885 million by the end of 2030 from US$ 3,834 million in 2021, at a CAGR of 5.0%
Meta Keywords: male infertility market Size, male infertility market share, male infertility market trend, male infertility market Forecast, male infertility market insight